Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2007 Aug 1;45(3):377-80.
doi: 10.1086/519426. Epub 2007 Jun 19.

Improving survival among HIV-infected injection drug users: how should we define success?

Editorial

Improving survival among HIV-infected injection drug users: how should we define success?

Gregory D Kirk et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Muga R, Langhor K, Tor J, et al. Survival of HIV-infected injection drug users (IDUs) in the era of highly active antiretroviral therapy, relative to sex- and age-specific survival among HIV-uninfected IDUs. Clin Infect Dis. 2006;45:370–6. (in this issue) - PubMed
    1. Kapadia F, Vlahov D, Donahoe RM, Friedland G. The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin Infect Dis. 2005;41:1027–34. - PubMed
    1. Des Jarlais DC, Friedman SR, Marmor M, et al. Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS. 1987;1:105–11. - PubMed
    1. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action on SeroConversion to AIDS and Death in Europe Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet. 2000;355:1131–7. - PubMed
    1. Pezzotti P, Galai N, Vlahov D, Rezza G, Lyles CM, Astemborski J. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences, Italian Seroconversion Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:275–82. - PubMed